Trans-Pacific Technology Fund
Venture capitalTaipei · Seed–Growth · 17 people tracked
Find your way into Trans-Pacific Technology Fund
Sign up to see every warm intro you have to Trans-Pacific Technology Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trans-Pacific Technology Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
TPTF is a multi-stage, technology-driven venture capital fund focused on disruptive platform technologies. It invests across advanced materials, health and life sciences, information and communications technology (ICT), IoT, and robotics/automation. Positioning itself as an innovation-driven, added-value partner, TPTF works actively with portfolio company leadership to support growth through capital, expertise, and global connections. Underpinned by a people-first philosophy that values entrepreneurs, the firm leverages an extensive network of collaborative partners to maintain a global investment scope spanning Asia, North America, and Europe.
Source: firm website, verified Oct 1, 2026.
Team · 17 people
from the firm's website & public directoriesWhat they invest in
from 10 of 13 portfolio companiesHealthtech ×7Biotech ×6Medical Devices ×3AI & Machine Learning ×2Digital Health ×2Enterprise Software ×2AgTech ×1Cloud Computing ×1
HQs:United States×7Indonesia×2Taiwan×1
Investments · 13 tracked
founders shown can be your intro pathBy year:2018 · 22017 · 12014 · 14 dated
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.
AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US
Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)
Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more
Pyxis Oncology develops antibody-drug conjugates and immunotherapies targeting difficult-to-treat cancers to improve patient outcomes.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Thomas Civik(Interim Chief Executive Officer, Director)
BoardDavid Steinberg(Executive Officer, Director)inChristoph Westphal(Director)Geeta Vemuri(Director)inJak Knowles(Director)John Flavin(Director)
Co-investorsAgent CapitalLifeSci Venture PartnersLongwood FundPfizer Venture InvestmentsRA CapitalRTW Investments L.P.
Bened Biomedical develops probiotic products focused on neurological health, serving customers across more than 40 markets worldwide through regionally located manufacturing partners.
BiotechHealthtechWellness & FitnessTaipei, TW
Crown Bioscience is a contract research organization based in California providing discovery, preclinical, and translational platforms and services for oncology and immuno-oncology drug development.
BiotechHealthtechMedical DevicesCalifornia, US
Co-investorsAcorn Pacific VenturesGRC SinogreenLAVLilly Asia VenturesQiming Venture Partners
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOCV PartnersOMX Ventures+2 more
Kata.ai provides a large language model that lets brands and enterprises build intelligent chatbots for marketing, commerce, and behavioral data collection across social and chat apps such as LINE, Facebook, and WhatsApp.
AI & Machine LearningE-commerceEnterprise SoftwareHR TechMarketing TechSaaSSales Tech
Ahmad Rizqi Meydiarso(Founder)inChristian FrankeIrzan Raditya(Founder)inReynir Fauzan(Founder)inWahyu Wrehasnaya(Founder)in
Co-investors500 GlobalAC VenturesRed Sails InvestmentSpiral VenturesConvergence VenturesMDI Ventures
Rancher is an open-source container management platform that provides enterprise-grade Kubernetes orchestration and management across data centers, clouds, and edge environments.
Cloud ComputingDeveloper ToolsEnterprise Software
Sheng Liang(Founder)inDarren Shepherd(Founder)Shannon Williams(Founder)Will Chan(Founder)
Co-investorsGRC SinogreenMayfield FundTitanium VenturesNexus Venture Partners
Rey.id addresses inefficiencies in the healthcare industry through solutions targeting health service provision, fraud prevention, and chronic disease management.
Digital HealthHealthtechInsurTech
Co-investorsGenesia Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Applied BioCodeGet HealGoogol TechnologyHealMegaPro Therapeutics
Exits · 2
2 IPOsGinkgo BioworksNYSE: DNAPyxis OncologyNASDAQ: PYXS
Frequently asked questions
- How many investments has Trans-Pacific Technology Fund made?
- Trans-Pacific Technology Fund has 13 tracked investments, 2 of which have exited.
- What stage does Trans-Pacific Technology Fund invest at?
- Trans-Pacific Technology Fund invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Trans-Pacific Technology Fund focus on?
- Trans-Pacific Technology Fund focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Consumer, Data & Infrastructure, Deep Tech, Enterprise Software, Hardware, Healthtech, InsurTech, IoT, Medical Devices, New Materials, Robotics, SaaS.
- Where is Trans-Pacific Technology Fund located?
- Trans-Pacific Technology Fund is headquartered in Taipei, TW.
- Who does Trans-Pacific Technology Fund co-invest with?
- Trans-Pacific Technology Fund most often shares deals with GRC Sinogreen, B3 Holding, OMX Ventures, among 50 tracked co-investors.
Similar investors
Industrial Technology Investment Corporation is the venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), backing startups across multiple stages and sectors while providing access to ITRI's R&D resources.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Karista is an early-stage European venture capital firm founded in 2001 that invests in Health, DeepTech (Space & Defense) and Digital companies, typically leading rounds from Seed to Series B+.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Montis Capital is a Warsaw-based venture capital fund investing in teams with scalable business models and market-validated products, focused on Industry 4.0 and Life Science sectors.
















































